Decades of Ebola preparedness have produced vaccines, diagnostics and treatments, but many were built primarily around Zaire ebolavirus. A new perspective argues that future preparedness should span the wider ebolavirus genus, combining broader diagnostics, multivalent vaccines, conserved therapeutic targets and continuous genomic surveillance.
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.